nLIGHT (LASR) Q3 2026 Earnings Call Transcript

nLIGHT reported Q3 revenue of $73.8 million, up 11% year over year and above the high end of its prior guidance, with record non-GAAP products gross margin of 48.8% and adjusted EBITDA of $11.1 million versus $7.1 million a year earlier. Non-GAAP net income rose to $10.2 million, or $0.16 per diluted share, from $4.3 million, or $0.08, while Q4 revenue guidance is $84 million-$90 million and adjusted EBITDA guidance is $12 million-$18 million. Optical supply constraints deferred about $15 million of product revenue, which management expects to ship in the first half of 2027; the company also cited its $627 million multiyear JLWS award and ongoing investment to reduce China-related supply-chain exposure.

Analysis

The key issue is conversion, not demand: the delayed product sales—mostly advanced manufacturing—are a supply-dependent opportunity, not guaranteed near-term earnings. A slip beyond 1H27, cancellations, or further inventory accumulation would weaken the “timing only” explanation and expose working-capital risk. Resourcing outside China can improve resilience over time, but supplier qualification and possible insourcing create a near-term cost and execution trade-off; watch inventory turns and cash conversion alongside revenue.

The mix shift matters. Development growth and JLWS move LASR toward system-level defense work, but development gross margins remain modest and program timing can make quarterly profitability noisy. The $627 million award supports strategic positioning, not a basis to extrapolate near-term revenue or margins; fielding in 2028 leaves schedule, funding, and production-rate risk. Conversely, demonstrated system integration and manufacturing yield could strengthen customer stickiness and raise barriers for component-only rivals.

For the next quarter, guidance implies better operating leverage from volume even as product margins normalize from unusually favorable Q3 conditions. Do not extrapolate the Q3 margin peak. Over 6–18 months, successful optical-source diversification and shipment recovery could improve earnings quality; failure would pressure both growth and margins. The call provides no valuation or share-price context, so avoid sizing a valuation-driven position. Verify supplier qualification milestones, customer shipment acceptance, and whether advanced-manufacturing demand persists independently of the catch-up shipments.

Key Decisions for Investors

• Keep LASR on a catalyst watch rather than chase a single-quarter beat: seek confirmation over the next 1–3 months that Q4 volume growth converts to cash and product gross margin remains above management’s stated 40% comfort level.
• Consider a staged, small long LASR only after evidence of optical supply recovery and catch-up shipments; treat the reported $15 million as at-risk conversion until orders, delivery timing, and customer acceptance are verified. No price target is warranted without valuation and market-price data.
• Falsification / risk trigger: reduce the thesis if shipment recovery slips beyond 1H27, inventory rises faster than sales without improving availability, or product gross margin sustains below 40%; also monitor JLWS schedule/funding updates for a change to the 2028 fielding path.
• Do not underwrite the full JLWS award value as near-term backlog economics: track development gross margin, program deliverables, and any evidence that system-level work is progressing toward repeatable production rather than remaining development-heavy.